MedTrace Logo

Effects and Tolerability With Clenpiq and Low Residue Diet

NCT04150133 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2022-03-16

No results posted yet for this study

Summary

The Efficacy of Clenpiq utilized per FDA labeling, with a low residue diet the day before colonoscopy.

Conditions

  • Colonoscopy Preparation

Interventions

OTHER

Low Residue Diet

Variable cohort will eat 3 low residue meals on the day prior to their planned colonoscopy

Sponsors & Collaborators

  • Ferring Pharmaceuticals

    collaborator INDUSTRY

  • Hillmont GI

    lead OTHER

Principal Investigators

  • Gerald Bertiger, MD · Hillmont GI

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-21
Primary Completion
2021-01-01
Completion
2021-10-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04150133 on ClinicalTrials.gov